In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to ...
The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
Statistics also help predict future needs through demographic trends, changing drug availability, and evolving use patterns. This forward-thinking approach enables proactive planning for future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results